Home Journals Articles Updates About
CN
image
收藏切换
The role of glucose metabolism reprogramming and its targeted therapeutic agents in inflammation-related diseases
收藏切换
PDF
Yi WEI1, Xiao-man JIANG1, Shi-lin XIA1, Jing XU1, Ya LI1, Ran DENG2, Yan WANG1, Hong WU1, *
Acta Pharmaceutica Sinica | 2024, 59(3) : 511 - 519
Less
收藏切换
Acta Pharmaceutica Sinica | 2024, 59(3): 511-519
• Reviews •
The role of glucose metabolism reprogramming and its targeted therapeutic agents in inflammation-related diseases
Full
Yi WEI1, Xiao-man JIANG1, Shi-lin XIA1, Jing XU1, Ya LI1, Ran DENG2, Yan WANG1, Hong WU1, *
Affiliations
  • 1. Key Lab of Xin′an Medicine, Ministry of Education, Anhui Province Key Laboratory of Research and Development of Chinese Medicine, School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
  • 2. School of Integrated Traditional and Western Medicine, Anhui University of Chinese Medicine, Hefei 230012, China
Published: 2024-03-12 doi: 10.16438/j.0513-4870.2023-0993
Outline
收藏切换

Cells undergo glucose metabolism reprogramming under the influence of the inflammatory microenvironment, changing their primary mode of energy supply from oxidative phosphorylation to aerobic glycolysis. This process is involved in all stages of inflammation-related diseases development. Glucose metabolism reprogramming not only changes the metabolic pattern of individual cells, but also disrupts the metabolic homeostasis of the body microenvironment, which further promotes aerobic glycolysis and provides favourable conditions for the malignant progression of inflammation-related diseases. The metabolic enzymes, transporter proteins, and metabolites of aerobic glycolysis are all key signalling molecules, and drugs can inhibit aerobic glycolysis by targeting these specific key molecules to exert therapeutic effects. This paper reviews the impact of glucose metabolism reprogramming on the development of inflammation-related diseases such as inflammation-related tumours, rheumatoid arthritis and Alzheimer's disease, and the therapeutic effects of drugs targeting glucose metabolism reprogramming on these diseases.

glucose metabolism reprogramming  /  aerobic glycolysis  /  inflammation-related disease  /  inflammatory microenvironment  /  targeted therapy
Yi WEI, Xiao-man JIANG, Shi-lin XIA, Jing XU, Ya LI, Ran DENG, Yan WANG, Hong WU. The role of glucose metabolism reprogramming and its targeted therapeutic agents in inflammation-related diseases[J]. Acta Pharmaceutica Sinica, 2024 , 59 (3) : 511 -519 . DOI: 10.16438/j.0513-4870.2023-0993
Appendix
Less
Year 2024 volume 59 Issue 3
PDF
884
768
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2023-0993
  • Receive Date：2023-08-24
  • Online Date：2025-11-28
  • Published：2024-03-12
Article Data
Affiliations
History
  • Received：2023-08-24
  • Revised：2023-09-21
Funding
Affiliations
    1. Key Lab of Xin′an Medicine, Ministry of Education, Anhui Province Key Laboratory of Research and Development of Chinese Medicine, School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
    2. School of Integrated Traditional and Western Medicine, Anhui University of Chinese Medicine, Hefei 230012, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2023-0993
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House